Loomis, Sayles & Company’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,818,123
| Closed | -$28.1M | – | 883 |
|
|
2018
Q3 | $28.1M | Sell |
1,818,123
-6,936
| -0.4% | -$107K | 0.06% | 166 |
|
|
2018
Q2 | $29.2M | Sell |
1,825,059
-6,242
| -0.3% | -$100K | 0.06% | 158 |
|
|
2018
Q1 | $23.7M | Sell |
1,831,301
-55,048
| -3% | -$711K | 0.05% | 198 |
|
|
2017
Q4 | $23.7M | Buy |
1,886,349
+33,939
| +2% | +$426K | 0.05% | 227 |
|
|
2017
Q3 | $24.5M | Sell |
1,852,410
-53,745
| -3% | -$710K | 0.05% | 223 |
|
|
2017
Q2 | $30.1M | Buy |
1,906,155
+11,345
| +0.6% | +$179K | 0.07% | 168 |
|
|
2017
Q1 | $27.1M | Sell |
1,894,810
-41,604
| -2% | -$594K | 0.07% | 185 |
|
|
2016
Q4 | $24.8M | Buy |
1,936,414
+89,568
| +5% | +$1.15M | 0.06% | 208 |
|
|
2016
Q3 | $24.6M | Sell |
1,846,846
-359,703
| -16% | -$4.78M | 0.06% | 203 |
|
|
2016
Q2 | $24.2M | Buy |
2,206,549
+237,438
| +12% | +$2.6M | 0.07% | 220 |
|
|
2016
Q1 | $18M | Buy |
1,969,111
+154,814
| +9% | +$1.42M | 0.05% | 301 |
|
|
2015
Q4 | $17.6M | Buy |
+1,814,297
| New | +$17.6M | 0.05% | 325 |
|